J. Gerloff

发表

A multicenter phase 1 study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody targeting αv integrins, in progressive castration-resistant prostate cancer with bone metastases after chemotherapy.

M. Wirth, H. Lannert, S. Zastrow, 2014, European urology.

Cerebrospinal fluid uptake and peripheral distribution of centrally acting drugs: Relation to lipid solubility

D. Greenblatt, H. Ochs, D. Abernethy, 1985, The Journal of pharmacy and pharmacology.

Assessment of cardiac risk 10 days after uncomplicated myocardial infarction.

I. McDonald, V. M. Jelinek, J. Gerloff, 1982, British medical journal.

Radiofrequency ablation of idiopathic ventricular tachycardia.

W. Hua, J. Vohra, J. Gerloff, 1996, Australian and New Zealand journal of medicine.

Effects of changing liver blood flow by exercise and food on kinetics and dynamics of saruplase

L. Huisman, A. Cohen, R. Schoemaker, 1995, Clinical pharmacology and therapeutics.

PKU patients on a relaxed diet may be at risk for micronutrient deficiencies

C. Baerwald, W. Kiess, J. Gerloff, 2014, European Journal of Clinical Nutrition.

Pharmacokinetics of Alprostadil (Prostaglandin E1) in Patients Undergoing Haemodialysis

W. Cawello, H. Seyberth, U. Kuhlmann, 1999 .

Radiofrequency catheter ablation for paroxysmal supraventricular tachycardia: a report of 135 procedures.

D. Hunt, J. Vohra, J. Gerloff, 1993, Australian and New Zealand journal of medicine.

Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases after chemotherapy.

M. Wirth, H. Lannert, S. Zastrow, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pharmacokinetics of Tramadol and Bioavailability of Enteral Tramadol Formulations 4th Communication: Drops (without ethanol)

R. Becker, J. Gerloff, R. Terlinden, 2000, Arzneimittelforschung.

PHARMACOKINETICS AND DISPOSITION

H. Dengler, J. Gerloff, S. Poche, 1997 .

In vitro-Hemmung der durch Fremdserum induzierten Thrombocytenaggregation

J. Gerloff, K. N. Kaulla, 1972 .

Bioavailability of tramadol after i.m. injection in comparison to i.v. infusion.

J. Gerloff, H. Beier, W. Lintz, 1999, International journal of clinical pharmacology and therapeutics.

The Dual Sample Aggregometer

J. Gerloff, K. V. von Kaulla, 1972, Thrombosis and Haemostasis.

Pharmacokinetics and absolute bioavailability of lansoprazole

J. Gerloff, K. Heintze, H. Barth, 1996, European Journal of Clinical Pharmacology.

Pharmacokinetics of Saruplase, a Recombinant Unglycosylated Human Single-Chain Urokinase-Type Plasminogen Activator and Its Effects on Fibrinolytic and Haemostatic Parameters in Healthy Male Subjects

G. Dooijewaard, A. Cohen, C. Kluft, 1993, Thrombosis and Haemostasis.

Final analysis: A multicenter phase I study of EMD 525797 (DI17E6), a novel humanized monoclonal antibody to human αv integrins, in progressive castrate-resistant prostate cancer with bone metastases after chemotherapy.

M. Wirth, H. Lannert, S. Zastrow, 2012, Journal of Clinical Oncology.

Nifedipine: Kinetics and dynamics after single oral doses

D. Greenblatt, H. Ochs, J. Gerloff, 1984, Klinische Wochenschrift.